A Daughter’s Legacy Fuels a $2.3M Tech Lifeline for Cancer Care in NY

SYRACUSE, NY – August 04, 2026 – In an age saturated with abstract tech promises, a tangible, life-altering investment is taking shape across Central New York. The Saint Agatha Foundation, a regional philanthropic powerhouse, has announced a record-breaking $2.3 million grant, channeling funds directly into the technological frontline of the fight against breast cancer. This infusion of capital will reach eight healthcare providers across a dozen counties, upgrading the tools doctors use to detect, diagnose, and treat a disease that affects one in eight women in the state.

This is not just another corporate donation. It’s a strategic deployment of resources aimed at leveling the playing field, bringing state-of-the-art medical technology to communities that often find themselves on the wrong side of the healthcare access divide. The investment promises a direct impact on patient outcomes, from earlier detection to more precise surgeries, fundamentally reshaping the standard of care in the region.

A Mission Forged in Loss, Focused on Impact

Behind this multimillion-dollar investment is a deeply personal story of loss and legacy. The Saint Agatha Foundation was established in 2004 by Laurie Mezzalingua during her own 12-year battle with breast cancer. Before her passing in 2009, she left her estate to the foundation, creating one of Onondaga County's largest philanthropic entities with a clear mission. Her mother, Kathy Mezzalingua, now serves as the foundation's Board President, carrying that mission forward.

“When breast cancer took my daughter Laurie from us too early, she asked me to 'just help women,'” said Mezzalingua. “And that's what we're doing with this new round of grant funding. We can't wait to see the impact.”

For nearly two decades, “helping women” primarily meant providing direct financial assistance. The foundation has distributed over $13.5 million to more than 7,000 patients, covering everything from insurance co-payments and prescription costs to transportation and living expenses for the uninsured and underinsured. Last year alone, it disbursed over $2 million for this purpose.

This new $2.3 million grant marks a pivotal expansion of that strategy. While maintaining its commitment to direct patient aid, the foundation is now making its largest-ever investment in capital improvements. With assets totaling nearly $79 million, this strategic shift leverages its financial strength to address the root infrastructure of care. By funding technology, the organization moves upstream to enhance prevention and early detection, aiming to change patient trajectories before they face overwhelming financial burdens.

From 2D to 3D: Bridging the Healthcare Technology Divide

For many patients in Central New York, the difference between this grant and the status quo can be measured in millimeters and months. A significant portion of the funding is allocated for upgrading diagnostic imaging technology, a move that directly confronts regional healthcare disparities. Rural and lower-income communities often rely on older equipment, which can lead to missed diagnoses or stressful, unnecessary callbacks for further testing.

Oswego Hospital provides a clear example of the grant's impact. “This investment… is a game-changer for patients in Oswego County,” explained Margaret Barclay, Executive Director of the Oswego Health Foundation. A $225,000 portion of the grant will allow its Central Square Medical Center to upgrade from a 2D mammography unit to a 3D system, also known as breast tomosynthesis. An earlier grant is already funding advanced software to reduce interpretation times.

The clinical benefits of this single upgrade are profound. Studies show that 3D mammography can increase the detection rate of invasive breast cancers by up to 40%, particularly in women with dense breast tissue. It also reduces recall rates by as much as 40%, saving patients from the anxiety and cost of follow-up appointments. In a state where Black women are more likely to be diagnosed at an advanced stage and Medicaid recipients have lower screening rates, providing access to superior diagnostic tools is a critical step toward equity.

Beyond imaging, the grants will fund precision surgical navigation tools and advanced radiation therapy systems. Technologies like magnetic marker navigation allow surgeons to locate and remove tumors with greater accuracy during lumpectomies, preserving healthy tissue and reducing the need for painful and costly repeat surgeries. These are not incremental improvements; they are transformative technologies that improve the patient experience and support better long-term outcomes.

A Regional Transformation in Breast Cancer Care

The ripple effect of this investment will be felt across a vast swath of Central New York. The eight grant recipients—Cortland Memorial Foundation, Mohawk Valley Health System, Oswego Hospital, Guthrie Lourdes Hospital, Rome Health, Samaritan Medical Center Foundation, St. Joseph's Hospital Health Center, and UHS Foundation—serve a 12-county area that includes Broome, Cayuga, Chenango, Cortland, Jefferson, Madison, Oneida, Onondaga, Otsego, Oswego, Saint Lawrence, and Tompkins counties.

This geographic spread is deliberate, targeting a region with a clear and present need. Breast cancer is the second leading cause of cancer-related death for women in New York State, with nearly 18,000 new diagnoses each year. In communities like Syracuse and Watertown, which face significant poverty rates, access to specialized care can be a major hurdle. By equipping local hospitals with advanced technology, the Saint Agatha Foundation is decentralizing excellence and ensuring that a patient’s zip code does not determine their quality of care.

While other philanthropic bodies like the Central New York Community Foundation and the Health Foundation for Western and Central New York contribute significantly to regional health, Saint Agatha’s highly targeted, large-scale investment in breast cancer technology fills a unique and vital niche. It complements its ongoing direct aid by strengthening the very systems patients rely on, creating a more robust and equitable healthcare ecosystem for thousands of women in the years to come.